KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
11.51
-0.38 (-3.20%)
At close: Jul 2, 2024, 4:00 PM
11.55
+0.04 (0.35%)
After-hours: Jul 2, 2024, 5:06 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $485.59 million as of July 2, 2024. Its market cap has increased by 57.71% in one year.
Market Cap
485.59M
Enterprise Value
416.26M
1-Year Change
57.71%
Ranking
Category
Stock Price
$11.51
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $485.59M, an increase of 275.55%. That is a compound annual growth rate of 15.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 485.60M | 14.72% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 514.28M |
| Altimmune | 510.50M |
| Mereo BioPharma Group | 509.18M |
| Astria Therapeutics | 507.95M |
| Sharecare | 502.47M |
| Mind Medicine (MindMed) | 498.44M |
| Oculis Holding AG | 495.81M |
| ZimVie | 494.74M |